184 related articles for article (PubMed ID: 22647538)
1. Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis.
Kim S; Mi L; Zhang L
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):312-7. PubMed ID: 22647538
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis.
Zhao JJ; Lou XL; Chen HW; Zhu FT; Hou YQ
Cell Mol Biol Lett; 2018; 23():22. PubMed ID: 29760745
[TBL] [Abstract][Full Text] [Related]
3. Serum decoy receptor 3, a potential new biomarker for sepsis.
Hou YQ; Xu P; Zhang M; Han D; Peng L; Liang DY; Yang S; Zhang Z; Hong J; Lou XL; Zhang L; Kim S
Clin Chim Acta; 2012 Apr; 413(7-8):744-8. PubMed ID: 22280900
[TBL] [Abstract][Full Text] [Related]
4. Increased circulating levels of tumor necrosis factor-like cytokine 1A and decoy receptor 3 correlate with SYNTAX score in patients undergoing coronary surgery.
Li XY; Hou HT; Chen HX; Wang ZQ; He GW
J Int Med Res; 2018 Dec; 46(12):5167-5175. PubMed ID: 30213220
[TBL] [Abstract][Full Text] [Related]
5. Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis.
Xiu Z; Shen H; Tian Y; Xia L; Lu J
Cytokine; 2015 Apr; 72(2):185-9. PubMed ID: 25647275
[TBL] [Abstract][Full Text] [Related]
6. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis.
Bamias G; Kaltsa G; Siakavellas SI; Papaxoinis K; Zampeli E; Michopoulos S; Zouboulis-Vafiadis I; Ladas SD
Clin Immunol; 2010 Nov; 137(2):242-9. PubMed ID: 20675196
[TBL] [Abstract][Full Text] [Related]
7. Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis.
Maruyama H; Hirayama K; Nagai M; Ebihara I; Shimohata H; Kobayashi M
Clin Rheumatol; 2016 Oct; 35(10):2469-76. PubMed ID: 27251675
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis.
Bamias G; Siakavellas SI; Stamatelopoulos KS; Chryssochoou E; Papamichael C; Sfikakis PP
Clin Immunol; 2008 Nov; 129(2):249-55. PubMed ID: 18757243
[TBL] [Abstract][Full Text] [Related]
9. TNFSF/TNFRSF cytokine gene expression in sickle cell anemia: Up-regulated TNF-like cytokine 1A (TL1A) and its decoy receptor (DcR3) in peripheral blood mononuclear cells and plasma.
Safaya S; Alfarhan M; Sulaiman A; Alsulaiman A; Al-Ali A
Cytokine; 2019 Nov; 123():154744. PubMed ID: 31255916
[TBL] [Abstract][Full Text] [Related]
10. Serum decoy receptor 3 (DcR3): a promising biomarker for atopic asthma in children.
Kamal A; Abdelmegeid AK; Gabr MAM; Basanti CWS
Immunol Res; 2021 Dec; 69(6):568-575. PubMed ID: 34383195
[TBL] [Abstract][Full Text] [Related]
11. Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis.
Aiba Y; Harada K; Komori A; Ito M; Shimoda S; Nakamura H; Nagaoka S; Abiru S; Migita K; Ishibashi H; Nakanuma Y; Nishida N; Kawashima M; Tokunaga K; Yatsuhashi H; Nakamura M
Liver Int; 2014 May; 34(5):679-88. PubMed ID: 24016146
[TBL] [Abstract][Full Text] [Related]
12. Serum decoy receptor 3 is a biomarker for disease severity in nonatopic asthma patients.
Chen MH; Kan HT; Liu CY; Yu WK; Lee SS; Wang JH; Hsieh SL
J Formos Med Assoc; 2017 Jan; 116(1):49-56. PubMed ID: 26911723
[TBL] [Abstract][Full Text] [Related]
13. Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients.
Yang M; Chen G; Dang Y; Luo D
Ups J Med Sci; 2010 Nov; 115(4):232-7. PubMed ID: 20977315
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease.
Bamias G; Kaltsa G; Siakavellas SI; Gizis M; Margantinis G; Zampeli E; Vafiadis-Zoumboulis I; Michopoulos S; Daikos GL; Ladas SD
Dig Liver Dis; 2012 Jan; 44(1):30-6. PubMed ID: 21978578
[TBL] [Abstract][Full Text] [Related]
15. Serum decoy receptor 3 is a useful predictor for the active status of chronic hepatitis B in hepatitis B e antigen-negative patients.
Hou Y; Xu P; Lou X; Liang D; Zhang M; Zhang Z; Zhang L
Tohoku J Exp Med; 2013 Aug; 230(4):227-32. PubMed ID: 23925044
[TBL] [Abstract][Full Text] [Related]
16. Quantification and detection of DcR3, a decoy receptor in TNFR family.
Chen J; Zhang L; Kim S
J Immunol Methods; 2004 Feb; 285(1):63-70. PubMed ID: 14871535
[TBL] [Abstract][Full Text] [Related]
17. Decoy receptor 3 is highly expressed in patients with rheumatoid arthritis.
Hayashi S; Miura Y; Tateishi K; Takahashi M; Kurosaka M
Mod Rheumatol; 2010 Feb; 20(1):63-8. PubMed ID: 19821006
[TBL] [Abstract][Full Text] [Related]
18. Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome.
Chen CY; Yang KY; Chen MY; Chen HY; Lin MT; Lee YC; Perng RP; Hsieh SL; Yang PC; Chou TY
Am J Respir Crit Care Med; 2009 Oct; 180(8):751-60. PubMed ID: 19644047
[TBL] [Abstract][Full Text] [Related]
19. Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients.
Hung SC; Hsu TW; Lin YP; Tarng DC
Clin J Am Soc Nephrol; 2012 Aug; 7(8):1257-65. PubMed ID: 22626963
[TBL] [Abstract][Full Text] [Related]
20. Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action.
Yang CR; Hsieh SL; Teng CM; Ho FM; Su WL; Lin WW
Cancer Res; 2004 Feb; 64(3):1122-9. PubMed ID: 14871847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
